Skip to main content
BMC Medical Research Methodology logoLink to BMC Medical Research Methodology
. 2023 Jan 27;23:26. doi: 10.1186/s12874-023-01850-7

Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC

R K Ismail 1,2,3,, F M N H Schramel 4, M van Dartel 3, A M G Pasmooij 3, C M Cramer-van der Welle 5, D L Hilarius 6, A de Boer 2,3, M W J M Wouters 1,7, E M W van de Garde 2,8
PMCID: PMC9881308  PMID: 36707787

Correction: BMC Medical Research Methodology 23, 1 (2023)

https://doi.org/10.1186/s12874-022-01760-0

Following publication of the original article [1], the authors requested to correct the word “first-line” to “second-line” in the article title.

The original article has been updated.

Reference

  • 1.Ismail RK, Schramel FMNH, van Dartel M, et al. Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from first-line immunotherapy in NSCLC. BMC Medical Research Methodology. 2023;23:1. doi: 10.1186/s12874-022-01760-0. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Medical Research Methodology are provided here courtesy of BMC

RESOURCES